🇺🇸 FDA
Patent

US 10385395

Diagnostic tools for response to 6-thiopurine therapy

granted A61PA61P35/00

Quick answer

US patent 10385395 (Diagnostic tools for response to 6-thiopurine therapy) held by The Regents of the University of California expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P35/00